Sign In
Buy EXEL
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026
Exelixis (EXEL) Q1 Earnings and Revenues Surpass Estimates
03:40pm, Wednesday, 06'th May 2020
Exelixis (EXEL) beats on earnings and sales in the first quarter and maintains annual outlook amid coronavirus.
BMO Capital Maintains Market Perform on Exelixis, Raises Price Target to $27
03:19pm, Wednesday, 06'th May 2020Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $21
12:47pm, Wednesday, 06'th May 2020Edited Transcript of EXEL earnings conference call or presentation 5-May-20 9:00pm GMT
09:23am, Wednesday, 06'th May 2020
Q1 2020 Exelixis Inc Earnings Call
Exelixis Inc (EXEL) Q1 2020 Earnings Call Transcript
05:01am, Wednesday, 06'th May 2020
EXEL earnings call for the period ending March 31, 2020.
Exelixis (EXEL) Q1 Earnings and Revenues Beat Estimates
10:25pm, Tuesday, 05'th May 2020
Exelixis (EXEL) delivered earnings and revenue surprises of 15.38% and 6.79%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Exelixis Q1 Adj. EPS $0.190 Beats $0.130 Estimate, Sales $226.900M Beat $214.940M Estimate
08:27pm, Tuesday, 05'th May 2020Exelixis Announces First Quarter 2020 Financial Results and Provides Corporate Update
08:05pm, Tuesday, 05'th May 2020
Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2020 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial an
Exelixis, Inc. to Host Earnings Call
07:00pm, Tuesday, 05'th May 2020
NEW YORK, NY / ACCESSWIRE / May 5, 2020 / Exelixis, Inc. (NASDAQ:EXEL) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 5, 2020 at 5:00 PM Eastern
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 5.)
Arcturus Therapeutics Ltd (...
ALX Oncology Announces Appointment of Rekha Hemrajani to Board of Directors
12:00am, Monday, 04'th May 2020
ALX Oncology today announced the appointment of Rekha Hemrajani to its Board of Directors.
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Exelixis Charts Are Pointed Higher, Look to Buy a Dip
05:14pm, Friday, 01'st May 2020
Exelixis : "I've liked this one all the way," said Jim Cramer to a caller during the 'Lightning Round' of Mad Money Thursday night. Exelixis is a genomics-based drug discovery company and the produc
Cramer Weighs In On Cracker Barrel, UPS And More
12:01pm, Friday, 01'st May 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer revealed that he is worried because Royal Dutch Shell plc ADR Class A (NYSE: RDS-A) has cut its dividend for the first time since the World War II. He
